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Study objective: to observe changes in perceived health in patients during a clinical trial of treatments for venous leg
ulceration.
Design: randomised prospective factorial trial in patients with venous ulceration. Each patient randomised to a bandage,
dressing and a drug. Perceived health assessed at entry and after 24 weeks.
Setting: outpatient departments and patient’s home.
Patients: two hundred patients presenting to two vascular services in Falkirk and Edinburgh with chronic (duration >2
months) non-healing venous ulceration.
Statistical analysis and main results: analysis using the Nottingham Health Profile revealed that after 24 weeks there
were significant improvements in all subscores (p<0.01) with the exception of social isolation (p=0.081). Patients with
healed ulceration had improved in energy, pain, emotion, sleep and mobility compared with those whose ulceration failed
to heal (p<0.05). Patients randomised to four layer bandaging had significantly better energy (diff=7.9, 95% CI 0.2,
15.6, p=0.04) and mobility (diff=4.5, 95% CI 0.0, 9.0, p=0.046). This difference could be explained largely by the
improved healing of patients randomised to this bandage system (67/97 vs. 50/103, OR=2.37, 95% CI 1.31, 4.27).
Conclusions: improvements in perceived health were significantly greater in patients whose ulcers had completely healed.
Methods of treatment which offer improved healing for patients with venous leg ulceration are likely to improve patients’
perceived health status.
Introduction Methods
It is widely acknowledged that chronic leg ulceration The trial was conducted in patients with current leg
has a major impact on patients’ quality of life, yet few ulceration, present for a minimum of 2 months and
studies have investigated this using tools specifically an area of ulceration with a minimum diameter of
designed to investigate problems associated with leg 10 mm, full details of which are given elsewhere.3
ulceration.1,2 Patients may experience benefits of treat- Patients underwent non-invasive investigation of the
ment above and beyond the simple healing of their cause of their ulceration and were classified according
ulcer, which may in turn lead to improved psy- to the aetiology (i) simple venous ulceration, (ii) com-
chological well being and changes to social and phys- plex venous ulceration or (iii) arterial ulceration. The
ical functioning. As part of a randomised factorial current trial presents the results of 200 patients who
trial,3 patients’ perceived health related quality of life were suffering from simple venous ulceration. Only
(HRQoL) was assessed at the start of treatment, and patients with ankle brachial pressure index (ABPI)
following 24 weeks to determine changes in perceived >0.8 were included in the pure venous arm of the
health associated with treating the leg ulceration. trial. The design was factorial with patients being
randomised to different bandage, dressing and drug
* Please address all correspondence to: P. J. Franks, Centre for regimens simultaneously. This paper refers to the com-
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(i) Drug regimens Comparison of presenting values with age/sex/social
class norms revealed significantly higher perceived
Patients were randomised double blind to receive pain (mean difference (diff)=22.2, 95% CI 18.3, 26.1,
p<0.001), and poorer mobility (diff=17.2, 95% CI 14.4,either oxpentifylline (Trental, Hoechst Roussel) 400 mg
three times daily, or identical placebo tablets. 20.0, p<0.001), whilst interference in social activities
was lower in the patients with leg ulceration (diff=
-2.4, 95% CI -4.1, -0.7, p=0.007), Table 1. None of
the other subscores achieved statistical significance,
(ii) Bandage regimens the next largest effect noted for energy with a mean
difference of 4.1.
The two treatments were the four layer bandage (4LB) As expected, there were substantial improvements
which consists of Velband (Johnson & Johnson), crepe in HRQoL after 24 weeks of treatment, Table 2. The
(Smith & Nephew), Elset (Seton) and Coban (3M)7 largest effects were noted for pain (diff=20.1, p<0.001)
compared with a single layer adhesive compression and sleep (diff=13.7, p<0.001), with smaller but none-
bandage-ACB (Granuflex, Convatec Ltd). Patients had theless significant improvements in mobility (diff=
bandages changed weekly, or occasionally more fre- 4.9, p<0.001), emotion (diff=5.3, p<0.001) and energy
quently if required. (diff=6.8, p=0.005). These changes in perceived health
were highly related to whether the areas of ulceration
achieved complete healing, Table 3. After adjustment
for baseline score the 24 week scores were significantly(iii) Dressing regimens
lower, indicating improvements for energy, pain, emo-
tion, sleep and mobility in patients whose ulcers hadPatients were randomised to receive either a simple
completely healed compared with those with areas ofNA dressing (Johnson & Johnson) or a hydrocolloid
ulceration remaining.dressing (Granuflex, Convatec). The dressing was
changed at the same visit as for the bandage.
At the first visit (or within 1 week) of starting
treatment patients were interviewed about their life-
(i) Trial of drug treatmentstyle. Included in this was the Nottingham Health
Profile (NHP), a well validated assessment of per-
Of the 200 patients, 101 were randomised double blindceived health recommended for use in patients with
to receive oxpentifylline 400 mg tds, compared withchronic diseases.8 The NHP produces scores for energy,
99 randomised to receive identical placebo tablets,pain, emotional reactions, sleep, social isolation and
Table 4. The largest difference was in sleep (-3.2, 95%physical mobility over a range from zero (no in-
CI-8.5,-2.1) but there were no significant differencesterference in health) to 100 (worst possible health). At
between scores for any of the subscores of the NHP,the end of the trial period of 24 weeks, patients were
even after adjustment for baseline scores.re-interviewed irrespective of whether their ulcer had
healed. For the comparison of healed vs. unhealed
ulceration, only patients who presented to the 24 week
visit with legs free of all areas of ulceration were
(ii) Trial of bandagesconsidered to have healed.
Comparison of the changes in NHP scores over 24
The randomisation was 97 to the 4LB compared withweeks were performed initially using paired t-test
103 to the ACB, both groups receiving similar pro-analysis, whilst comparison of the 24 week scores
portions of randomised dressings and randomisedbetween groups was performed using ANOVA with
drug treatment. From Table 5 it is clear that followingpresenting NHP scores entered as a covariate. All
adjustment for the presenting scores the 4LB wasanalysis was performed on an “intention to treat”
able to demonstrate significantly improved scores forbasis.
energy (diff=7.9, 95% CI 0.2, 15.6, p=0.040) and mo-
bility (diff=4.5, 95% CI 0.0, 9.0, p=0.046) in patients
being treated with 4LB, after adjustment for baseline
scores. The difference in these scores could be ex-Results
plained by the substantially higher healing in patients
treated with 4LB compared with ACB at 67/97 vs. 50/Of the 200 patients randomised the mean age was 69.6
years (range=35–94) of which 132 (66%) were women. 103 (OR=2.37, 95% CI 1.31, 4.27, p=0.003).
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Table 1. Comparison of scores between patients on the trial and age/sex/social class population norms.
n Population Sample mean Paired 95% CI t p
mean difference
Energy 194 20.2 24.3 4.1 (-0.9, 9.0) 1.63 0.10
Pain 193 10.6 32.8 22.2 (18.3, 26.1) 11.34 <0.001
Emotional reactions 192 10.7 10.0 -0.7 (-3.0, 1.5) -0.64 0.52
Sleep 192 22.2 24.9 2.7 (-1.2, 6.7) 1.36 0.18
Social isolation 195 7.4 5.1 -2.4 (-4.1, -0.7) 2.73 0.007
Physical mobility 190 12.5 29.6 17.2 (14.4, 20.0) 12.02 <0.001
Table 2. Change in NHP scores over 24 weeks.
n Mean initial Mean 24 weeks Paired 95% CI t p
difference
Energy 190 23.7 16.8 6.8 (2.0, 11.6) 2.82 0.005
Pain 188 32.8 12.7 20.1 (16.5, 23.8) 10.95 <0.001
Emotional reactions 188 10.0 4.7 5.3 (2.9, 7.7) 4.35 <0.001
Sleep 185 24.3 10.6 13.7 (9.6, 17.8) 6.56 <0.001
Social isolation 191 5.1 3.4 1.6 (-0.2, 3.4) 1.75 0.08
Physical mobility 185 29.4 24.6 4.9 (2.5, 7.2) 4.10 <0.001
Table 3. Nottingham Health Profile scores after 24 weeks: comparison between healed and unhealed ulceration. Unadjusted and
following adjustment for baseline score. Difference in score is unhealed-healed after adjustment for baseline.
n Mean (s.e.) n Mean (s.e.) Unadjusted Adjusted mean Adjusted
healed unhealed F p diff. (95% CI) F p
Energy 113 14.0 (2.7) 80 20.2 (3.5) 2.0 0.16 8.3 (0.5, 6.0) 4.51 0.035
Pain 113 8.7 (1.7) 79 19.5 (2.2) 16.1 <0.001 10.4 (5.8, 15.0) 20.56 <0.001
Emotional reactions 113 3.6 (1.0) 80 6.8 (1.5) 3.5 0.06 4.7 (1.5, 7.8) 8.61 0.004
Sleep 111 7.6 (1.4) 79 15.6 (2.5) 8.6 0.004 9.2 (4.1, 14.4) 12.91 <0.001
Social isolation 113 2.5 (0.9) 80 4.7 (1.6) 1.7 0.20 1.3 (-1.8, 4.4) 0.70 0.40
Physical mobility 113 20.7 (2.0) 79 30.4 (2.4) 9.5 0.002 4.7 (0.1, 9.3) 4.12 0.044
Table 4. Nottingham Health Profile scores: comparison of oxpentifylline with placebo. Unadjusted and following adjustment for
baseline score. Difference in score is oxpentifylline-placebo after adjustment for baseline.
Placebo Oxpentifylline
n Mean (s.e.) n Mean (s.e.) Unadjusted Adjusted mean diff. Adjusted
F p (95% CI) F p
Energy 96 14.5 (2.9) 97 18.7 (3.2) 0.95 0.33 2.8 (-5.0, 10.5) 0.51 0.48
Pain 95 13.9 (2.0) 97 12.4 (1.9) 0.31 0.58 0.7 (-4.0, 5.5) 0.09 0.76
Emotional reactions 96 4.3 (1.1) 97 5.5 (1.3) 0.44 0.51 1.5 (-1.7, 4.7) 0.89 0.35
Sleep 96 11.8 (2.2) 94 10.0 (1.7) 0.45 0.50 -3.2 (-8.5, 2.1) 1.46 0.23
Social isolation 96 2.2 (0.9) 97 4.6 (1.4) 1.98 0.16 1.0 (-2.1, 4.1) 0.42 0.52
Physical mobility 95 22.8 (2.3) 97 26.5 (2.2) 1.34 0.25 0.7 (-3.9, 5.3) 0.10 0.75
Table 5. Nottingham Health Profile score: comparison of four layer bandaging with adhesive compression bandage. Unadjusted and
following adjustment for baseline score. Mean difference is ACB-4LB after adjustment for baseline.
4LB ACB
n Mean (s.e.) n Mean (s.e.) Unadjusted Adjusted mean Adjusted
F p diff. (95% CI) F p
Energy 95 13.6 (2.8) 98 19.5 (3.2) 1.90 0.17 7.9 (0.2, 15.6) 4.26 0.040
Pain 95 11.9 (1.9) 97 14.3 (2.0) 0.76 0.39 2.2 (-2.5, 7.0) 0.88 0.35
Emotional reactions 95 4.2 (1.2) 98 5.7 (1.2) 0.79 0.38 1.0 (-2.2, 4.1) 0.38 0.54
Sleep 94 10.6 (2.0) 96 11.2 (1.9) 0.04 0.84 0.4 (-4.8, 5.6) 0.03 0.87
Social isolation 95 3.8 (1.3) 98 3.0 (1.0) 0.23 0.64 -0.3 (-3.3, 2.8) 0.04 0.85
Physical mobility 95 22.2 (2.1) 97 27.0 (2.3) 2.29 0.13 4.5 (0.0, 9.0) 4.04 0.046
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Table 6. Nottingham Health Profile: comparison of NA and hydrocolloid dressings. Unadjusted and following adjustment for baseline
score. Difference in score is hydrocolloid-NA after adjustment for baseline.
NA Hydrocolloid
n Mean (s.e.) n Mean (s.e.) Unadjusted Adjusted mean diff. Adjusted
F p (95% CI) F p
Energy 95 14.6 (3.0) 98 18.5 (3.1) 0.82 0.37 2.6 (-5.1, 10.4) 0.45 0.50
Pain 95 13.4 (1.9) 97 12.9 (2.0) 0.03 0.87 0.0 (-4.8, 4.8) <0.01 0.99
Emotional reactions 95 4.5 (1.2) 98 5.4 (1.3) 0.25 0.62 0.8 (-2.3, 4.0) 0.28 0.60
Sleep 93 10.9 (2.0) 97 10.9 (1.9) <0.01 0.99 0.1 (-5.2, 5.4) <0.01 0.96
Social isolation 95 3.1 (1.2) 98 3.7 (1.1) 0.10 0.75 1.3 (-1.7, 4.4) 0.77 0.38
Physical mobility 95 26.1 (2.1) 97 23.2 (2.4) 0.82 0.37 -3.0 (-7.5, 1.5) 1.76 0.19
(iii) Trial of dressings also considerably higher than age-sex norms, analysis
was not performed to determine whether these dif-
Randomisation produced 102 patients on hydrocolloid ferences were statistically higher than the age-sex norm
compared with 98 on NA dressings, Table 6. The controls. However, using a case control method,
mean scores were similar between groups, the largest Hamer et al. (1994) found significantly higher pain
difference seen in mobility (diff=-3.0, 95% CI -7.5, scores in 88 patients from the Wirral with leg ulceration
1.5), but this did not approach a standard level of compared with 70 controls (mean=45 vs. 15, p<0.05).10
statistical significance. There were higher scores for energy loss in the patients
with ulceration (mean=58 vs. 24, p<0.05), but no
difference in emotional reactions. No evidence was
given for the impact of ulceration on sleep, mobility
(iv) Withdrawal of treatment nor social isolation. Whilst the results of the current
study concur with the differences in pain, the energy
In all, 65/200 (32.5%) withdrew from at least one arm scores were only slightly higher than those expected
of the trial over 24 weeks of treatment. Of these 26 from the population norm. Moreover, the current study
(13%) withdrew first from the bandage regimen with has provided evidence that physical mobility was
or without simultaneous withdrawal from the ran- significantly poorer in patients with venous ulceration
domised bandage and dressing treatment (5 4LB, 21 compared with the age/sex/social class norms. In a
ACB), 14 (7%) first from drug treatment (eight ox- recent study of 758 patients suffering from leg ul-
pentifylline, six placebo) and 32 (16%) first from the ceration, the difference between age/sex norms and
dressing (22 NA, 12 hydrocolloid). Only changes in the patients was significantly higher in men than
pain were significantly different between those women for energy, pain, sleep and social isolation.11
patients who remained on treatment vs. those who This suggests that it is men who suffer from their
withdrew, following adjustment for presenting scores
ulceration to a greater extent than women. Moreover,(mean -24.1 on treatment vs. -12.0 withdrew, F=
these results also indicated that the impact was greatest4.63, p=0.033).
for the youngest patients (<65 years) over all subscores
of the NHP.
It is frequently cited that social isolation is com-
pounded by the presence of ulceration. Whilst un-Discussion
doubtedly ulceration has been associated with poor
mobility and restrictions on travelling,1,10 evidence ofWhilst clinicians may believe that leg ulceration has a
a direct link of leg ulceration to social isolation ismajor impact on their patients’ perceived well being,
sparse. In the Wirral, patients did go out on a regularthere have been relatively few studies which have
basis, but most felt that they went out less frequentlyinvestigated this aspect in detail. In 1993 Lindholm et
because of their ulcer. Similarly, personal interviewsal. used the Nottingham Health Profile to compare 125
of 62 patients with leg ulceration in the U.S.A. foundpatients with leg ulceration with age-sex norms from
that 81% believed that their mobility was adverselypopulation studies.9 Perceived pain was significantly
affected by their ulcer.1 In the present study poorhigher in men than women, with men having five
physical mobility was associated with leg ulceration,times the score for age norms, and women 2.5 times
but social isolation was significantly lower in patientstheir norms. Mobility deficits were also significantly
higher in men than women. Whilst other scores were with leg ulceration compared with age/sex norms.
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